FDA: Yet Another Blood Pressure Medication Recall Due To Cancer Concerns

This time it’s Lupin Pharmaceuticals Inc. recalling all batches of their irbesartan tablets as well as their irbesartan plus hydrochlorothiazide tablets.

Read the full post on Forbes - Healthcare

Bruce Y. Lee, Senior Contributor